Safety and Tolerability of Shortened Updosing With 7 Injections of Subcutaneous Allergen Immunotherapy

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.978
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Patients on Subcutaneous Allergen Immunotherapy Are at Risk of Intramuscular Injections

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis

Allergy, Asthma and Immunology Research
ImmunologyPulmonaryAllergyRespiratory Medicine
2018English

Safety of Subcutaneous Allergen Immunotherapy in Children: A Retrospective Review and Bird Eye to Literature

Turkish Journal of Pediatrics
Child HealthPediatricsPerinatology
2018English

Immunotherapy – 2071. Strail Levels Decreased After Allergen-Subcutaneous Specific Immunotherapy

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

A Novel Approach in Allergen-Specific Immunotherapy: Combination of Sublingual and Subcutaneous Route

Pediatrics
Child HealthPediatricsPerinatology
2012English

Anaphylaxis During Specific Subcutaneous Immunotherapy Against Ragweed Allergen -- Case Record

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Safety and Tolerability of a Novel Peptide-Based Immunotherapy for Peanut Allergy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Subcutaneous Injections of Adrenalin

BMJ
1913English

Safety and Treatment Compliance of Subcutaneous Immunotherapy: A 30-Year Retrospective Study

Respiratory Medicine
PulmonaryRespiratory Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy